Loading insider details...
Beta
Latest Form 4 (Oct 6, 2026): Exercise/Conversion of 55,979 IBRX shares, $166.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | ImmunityBio, Inc. (IBRX) | Exercise/Conversion | 55,979 | $166.8K |
| Jul 7, 2026 | ImmunityBio, Inc. (IBRX) | Exercise/Conversion | 55,979 | $166.8K |
| Jun 29, 2026 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 26,000 | n/a |
| Jun 11, 2026 | ImmunityBio, Inc. (IBRX) | Grant/Award | 65,600 | n/a |
| Jun 20, 2025 | ImmunityBio, Inc. (IBRX) | Grant/Award | 162,786 | n/a |
| Jun 9, 2025 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 16,500 | n/a |
| Jun 17, 2024 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 16,500 | n/a |
| Jun 13, 2024 | ImmunityBio, Inc. (IBRX) | Grant/Award | 77,633 | n/a |
| Jun 20, 2023 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 11,300 | n/a |
| Jun 15, 2023 | ImmunityBio, Inc. (IBRX) | Grant/Award | 158,263 | n/a |